Greenstein Brayer Efrat L 4

4 · SKYX Platforms Corp. · Filed Apr 2, 2026

AI-generated summary of this filing

Updated Apr 2, 2026

SKYX Director Efrat Greenstein Brayer Receives 32,000-Share Award

What Happened

Efrat L. Greenstein Brayer, a director of SKYX Platforms Corp. (SKYX), was granted awards on 2026-03-31 reported as acquisitions (code A): 16,000 restricted shares (priced $0.00) and 16,000 derivative awards shown at $0.00. The restricted shares vested immediately upon grant; the derivative awards are subject to vesting terms under the company's non-employee director compensation program.
These were grants (not open-market purchases or exercises), so they increase her holdings through compensation rather than a market buy or sale.

Key Details

Transaction date: 2026-03-31; Form 4 filed: 2026-04-02 (appears timely).
Grants: 16,000 restricted stock units (vested immediately) + 16,000 derivative awards (both reported at $0.00).
Footnotes: F1 — restricted stock vested immediately upon grant; F2 — options (derivative awards) vest in 12 equal monthly installments beginning 4/30/2026; both granted under the non-employee director compensation program.
Shares owned after transaction: not specified in the provided filing excerpt.
Transaction code: A = Award/Grant.

Context

The restricted stock vested immediately, so those 16,000 shares should be owned outright post-grant. The 16,000 derivative awards vest over 12 months and are not exercises — they represent future potential equity if vesting conditions are met.
Grants to non-employee directors are common as part of board compensation and are routine; they reflect compensation, not necessarily the director buying stock as a bullish signal.

Form 4

Period: 2026-03-31

Director

Transactions

Award
Common Stock, no par value
[F1]
2026-03-31+16,000→ 73,000 total
Award
Stock Option (right to buy)
[F2]
2026-03-31+16,000→ 16,000 total
Exercise: $1.12From: 2026-04-30Exp: 2031-03-31→ Common Stock, no par value (16,000 underlying)

Holdings

Stock Option (right to buy)
Exercise: $12.34From: 2022-03-31Exp: 2027-03-11→ Common Stock, no par value (9,000 underlying)
9,000
Stock Option (right to buy)
Exercise: $3.28From: 2023-04-30Exp: 2028-04-05→ Common Stock, no par value (16,000 underlying)
16,000
Stock Option (right to buy)
Exercise: $1.09From: 2024-04-30Exp: 2029-04-04→ Common Stock, no par value (16,000 underlying)
16,000
Stock Option (right to buy)
Exercise: $1.26From: 2025-03-31Exp: 2030-03-27→ Common Stock, no par value (16,000 underlying)
16,000

Footnotes (2)

[F1]Represents shares of restricted stock, which vested immediately upon grant and were granted pursuant to the non-employee director compensation program.
[F2]Options vest in twelve equal monthly installments, on the last day of each month, beginning on April 30, 2026. These options were granted pursuant to the non-employee director compensation program.

Signature

/s/ Efrat L. Greenstein Brayer|2026-04-02

1 file